BIOCON LTD.
|
Market Cap.(`)
|
40640.31 Cr.
|
P/BV
|
1.94
|
Book Value (`)
|
174.86
|
|
52 Week High/Low ( ` )
|
405/270
|
FV/ML
|
5/1
|
P/E(X)
|
40.11
|
|
Book Closure
|
04/07/2025
|
EPS (`)
|
8.44
|
Div Yield (%)
|
0.15
|
(` in Crs.)
You can view the
Consolidated
Cash Flow
for the last 5 years.
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 1429.40 | 1297.80 | 643.00 | 771.60 | 846.20 |
| | | | | | |
| Net CashFlow From Operating Activities | 4061.20 | 2953.90 | 1852.50 | 1176.60 | 1159.70 |
| Net Cash Used In Investing Activities | -234.10 | -1004.50 | -14281.80 | -1699.10 | -3624.70 |
| Net Cash Used From Financing Activities | -1854.00 | -2332.70 | 13048.70 | 242.10 | 2564.00 |
| Foreign Exchange Gains / Losses | 31.20 | 2.90 | 21.70 | 3.30 | 7.10 |
| Adjustments On Amalgamation / Merger / Demerger And Others | 0.00 | 0.00 | 0.00 | 33.80 | 0.00 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 2004.30 | -380.40 | 641.10 | -243.30 | 106.10 |
| Cash And Cash Equivalents Begin of Year | 919.50 | 1299.90 | 653.70 | 897.00 | 790.90 |
| Cash And Cash Equivalents End Of Year | 2923.80 | 919.50 | 1294.80 | 653.70 | 897.00 |